Sign In
Buy TMCI
$4.31
-0.0700 (-1.60%)
At Close: Jul 31, 2026
Treace Medical Concepts (TMCI) Projected to Post Quarterly Earnings on Thursday
02:42am, Thursday, 30'th Oct 2025
Treace Medical Concepts (NASDAQ: TMCI - Get Free Report) is projected to issue its Q3 2025 results after the market closes on Thursday, November 6th. Analysts expect the company to announce earnings o
Treace to Report Third Quarter 2025 Financial Results on November 6, 2025
04:05pm, Thursday, 23'rd Oct 2025
PONTE VEDRA, Fla., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the
PONTE VERDE, Fla., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in th
Treace Medical Concepts, Inc. (TMCI) Investor Day 2025 Call Transcript
08:13pm, Wednesday, 03'rd Sep 2025
Treace Medical Concepts, Inc. (NASDAQ:TMCI ) Investor Day Call September 3, 2025 9:00 AM EDT Company Participants John Treace - Founder, Chairman & CEO Sean Scanlan - Chief Innovation Officer Conferen
Treace Medical Concepts, Inc. (TMCI) Q2 2025 Earnings Call Transcript
06:09am, Friday, 08'th Aug 2025
Treace Medical Concepts, Inc. (NASDAQ:TMCI ) Q2 2025 Earnings Conference Call August 7, 2025 4:30 PM ET Company Participants John T. Treace - Founder, Chairman & CEO Mark L.
Treace Medical (TMCI) Q2 Revenue Up 7%
10:20pm, Thursday, 07'th Aug 2025
Treace Medical (TMCI) Q2 Revenue Up 7%
Treace Medical Concepts (TMCI) Reports Q2 Loss, Beats Revenue Estimates
07:06pm, Thursday, 07'th Aug 2025
Treace Medical Concepts (TMCI) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.29. This compares to a loss of $0.34 per share a year ago.
Treace Medical Concepts Reports Second Quarter 2025 Financial Results
04:05pm, Thursday, 07'th Aug 2025
PONTE VEDRA, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgica
Treace Medical to Host Investor Day Highlighting New Products on September 3, 2025
04:01pm, Thursday, 07'th Aug 2025
PONTE VEDRA, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in th
PHILADELPHIA, July 01, 2025 (GLOBE NEWSWIRE) -- Maison Solutions Inc. (NASDAQ: MSS) Class Action Survives Motion to Dismiss:
Kuehn Law Encourages Investors of Treace Medical Concepts, Inc. to Contact Law Firm
10:08am, Wednesday, 11'th Jun 2025
NEW YORK , June 11, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Treace Medical Concepts, Inc. (NASDAQ: TMCI) b
Securities Lawsuit Alert: Treace Medical Concepts, Inc. (TMCI) Investors - Contact Levi & Korsinsky Before June 10, 2025
06:30pm, Tuesday, 10'th Jun 2025
NEW YORK, NY / ACCESS Newswire / June 10, 2025 / If you suffered a loss on your Treace Medical Concepts, Inc. (NASDAQ:TMCI) investment and want to learn about a potential recovery under the federal se
Investors can contact the law firm at no cost to learn more about recovering their losses
Securities Class Action Lawsuit Filed Against Treace Medical Concepts, Inc. (TMCI) - Levi & Korsinsky Represents Shareholders
04:30pm, Tuesday, 10'th Jun 2025
NEW YORK, NY / ACCESS Newswire / June 10, 2025 / If you suffered a loss on your Treace Medical Concepts, Inc. (NASDAQ:TMCI) investment and want to learn about a potential recovery under the federal se
NEW YORK, June 10, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed
